Walking Environments for Prediabetes
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does exclude people who have changed medications affecting study outcomes in the last 3 months or plan to change them. If you are on medications for lipids, blood pressure, anxiety, or depression, they will be tracked closely.
What data supports the effectiveness of the treatment Gray Walk, Green Walk for prediabetes?
Research shows that lifestyle changes, like increasing physical activity, can help prevent prediabetes from progressing to diabetes. A study found that a program encouraging physical activity led to an increase in daily steps and a trend towards weight loss in people with prediabetes, suggesting that similar walking treatments could be effective.12345
Is walking in different environments safe for people with prediabetes?
How does the treatment 'Gray Walk, Green Walk' differ from other treatments for prediabetes?
The 'Gray Walk, Green Walk' treatment is unique because it focuses on modifying walking environments to encourage physical activity, which is a key factor in managing prediabetes. Unlike medications or dietary changes, this approach emphasizes the role of the environment in promoting regular physical activity to help prevent the progression to type 2 diabetes.1011121314
What is the purpose of this trial?
Approximately 92 million U.S. adults (\~38% of population) have prediabetes (PreD). Because people with PreD are at high risk CMD, they are a target population for diabetes prevention programs. The focus is people with PreD because of their high risk for developing CMD and large numbers, providing an opportunity to investigate behavioral and environmental approaches as preventive measures in a well-defined population. Urbanization affords challenges and opportunities to public health that include exposure to obesogenic environments, air pollution, and psychosocial stressors. In healthy adults suggest exposure to nature has health benefits relative to exposure to built environments. Hypothesized mechanisms for health benefits of Greenspace exposure include increased physical activity (PA), attention restoration, stress reduction, and reduced exposure to pollution. Many of the health benefits are associated with reduced psychological and physiological stress leading to better autonomic functioning as assessed by heart rate variability (HRV) and other biomarkers. Multiple studies suggest that PA and exposure to natural environments may act together to improve health. Yet, aside from our preliminary studies, we are not aware of any studies that examined how physical activity may interact with exposure to urban Greenspace ('Green') compared with built urban environments ('Gray'), to reduce stress and improve health. The purpose of this proposed study is to conduct a randomized crossover trial comparing differences in the psychosocial and physiological effects of walking in urban Green and Gray spaces in adults with PreD.
Research Team
Mark Pereira, PhD
Principal Investigator
University of Minnesota
Eligibility Criteria
Adults aged 25-64 with prediabetes, classified as overweight or obese (BMI 20.0-39.9), who exercise less than 100 minutes per week and have stable weight for the last three months can join this trial. They must not be pregnant or breastfeeding, willing to keep their diet and exercise habits except for study requirements, own a smartphone, and pass a health questionnaire.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline measurements of anxiety, mood, heart rate variability, and other biomarkers are taken
Treatment
Participants engage in walking sessions in both Green and Gray environments in a randomized crossover design
Follow-up
Participants are monitored for changes in anxiety, mood, heart rate variability, and other biomarkers
Treatment Details
Interventions
- Gray Walk
- Green Walk
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor